Search Medical Condition
Please enter condition
Please choose location from dropdown

Pathumwan, Thailand Clinical Trials

A listing of Pathumwan, Thailand clinical trials actively recruiting patients volunteers.

RESULTS

Found (253) clinical trials

Exploration of the Neo-Vagina Study

A computer-administered questionnaire will collect quantitative demographic information and details about surgical history, neovaginal health, neovaginal practices, and sexual behavior including neovaginal intercourse and drug use history from each participant. The questionnaire can be completed online from any location or at the study clinic and will take about 15-20 minutes.

Phase N/A

0.0 miles

Learn More »

AMH Glucose Intolerance and Metabolic Syndrome in PCOS

To study the association between serum anti-Mullerian hormone (AMH) level and glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS). Glucose intolerance is detected by 2-hours 75 gram oral glucose tolerance test (OGTT). Metabolic syndrome is diagnosed by using the Harmonized criteria; the presence of any 3 ...

Phase N/A

0.0 miles

Learn More »

Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites

The goals of STSG donor site treatment are to accelerate wound healing, prevent infection, reduce pain, and maintain an optimal environment healing promotion. Biocellulose is an ultrafine fiber structure that can hold a large amount of water and has a cooling effect that decreases pain without causing an allergic reaction ...

Phase

0.0 miles

Learn More »

Association of HMOs and Allergic Manifestations

Parents of breast-fed infant from general pediatric clinic and allergy clinic of King Chulalongkorn Memorial Hospital were approached for informed about the research and ask to join this project After completed informed consent, demographic data was collected and filled in case record form Milk of mother in both allergic and ...

Phase N/A

0.0 miles

Learn More »

Client and Provider Preferences for HIV Care

This will be a cross-sectional questionnaire study. A self-administered questionnaire will be used to assess their satisfaction with current clinical services, preferences for location, frequency and provider of HIV services, as well as expectations and concerns. Furthermore, staff working at the different HIV-care to community-based organizations (CBOs) and the health ...

Phase N/A

0.0 miles

Learn More »

Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults

Previous study has shown the higher immunogenicity response among HIV-infected adults who received a single visit 4-site intradermal rabies booster vaccination than those who received the conventional intramuscular regimen. The investigators follow the persistence of these effects. Also, the regulatory T cell levels were examined after the rabies booster vaccination ...

Phase N/A

0.0 miles

Learn More »

Vaginal Progesterone Supplementation in the Management of Preterm Labor

This study evaluates the addition of vaginal progesterone in the management of preterm labor. Half of participants will receive vaginal progesterone, tocolysis and corticosteroid, while the other half will receive only tocolysis and corticosteroid.

Phase N/A

0.0 miles

Learn More »

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

The purpose of this study is to assess the effects of LIK066 on a variety of metabolic and inflammation biomarkers in patients with non-alcoholic steatohepatitis (NASH)

Phase

0.0 miles

Learn More »

Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab CIS and GEM; and CIS and GEM Alone in Subjects With Previously Untreated Unresectable Locally Advanced or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma

The study is being conducted to assess the safety and tolerability of (1) PEGylated Recombinant Human Hyaluronidase (PEGPH20) in combination with cisplatin (CIS) and gemcitabine (GEM) (PEGCISGEM), and (2) PEGPH20 in combination with CIS, GEM, and atezolizumab (PEGCISGEMATEZO) compared with (3) cisplatin and gemcitabine (CISGEM).

Phase

0.0 miles

Learn More »

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens

Title Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled, phase 3 clinical trial Hypotheses Seventeen (17) week rifapentine-based regimen In previously untreated individuals with active drug-susceptible pulmonary tuberculosis treated with eight weeks of rifapentine (P), isoniazid (H), pyrazinamide (Z) and ethambutol (E) followed by nine weeks of ...

Phase

0.0 miles

Learn More »